Travere Therapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $99.4M | $41.0M | $37.8M | $18.2M | $6.0M | $11.0K | $10.1K |
| Accounts Receivable | $13.9M | $18.5M | $12.5M | $8.0M | — | — | — |
| Inventory | $5.4M | $2.8M | $2.5M | $801.0K | — | — | — |
| Total Current Assets | $325.8M | $332.4M | $301.9M | $37.3M | $7.5M | $33.2K | $17.1K |
| Property, Plant & Equipment | $3.2M | $2.6M | $428.0K | $671.0K | $127.4K | $23.8K | $2.5K |
| Goodwill | $936.0K | $936.0K | $936.0K | $936.0K | — | — | — |
| Intangible Assets (Excl. Goodwill) | $184.8M | $182.0M | $161.5M | $94.3M | $2.0M | $2.2M | — |
| Total Assets | $520.3M | $525.3M | $512.3M | $135.5M | $20.5M | $2.4M | $19.6K |
| Liabilities | |||||||
| Accounts Payable | $18.9M | $7.5M | $7.6M | $7.1M | $3.6M | $1.0M | $340.1K |
| Total Current Liabilities | $85.7M | $83.3M | $87.0M | $107.5M | $36.6M | $5.8M | $555.9K |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $227.2M | $217.5M | $212.3M | $172.7M | $40.2M | $5.8M | $555.9K |
| Stockholders' Equity | |||||||
| Retained Earnings | $-177.7M | $-113.1M | $-65.2M | $-179.2M | $-68.2M | $-33.6M | $-121.3K |
| Total Stockholders' Equity | $293.1M | $307.8M | $300.0M | $-37.3M | $-19.7M | $-3.4M | $-536.3K |